Literature DB >> 21896745

Heparan sulfate binding by natural eastern equine encephalitis viruses promotes neurovirulence.

Christina L Gardner1, Gregory D Ebel, Kate D Ryman, William B Klimstra.   

Abstract

The Alphavirus genus of the family Togaviridae contains mosquito-vectored viruses that primarily cause either arthritogenic disease or acute encephalitis. North American eastern equine encephalitis virus (NA-EEEV) is uniquely neurovirulent among encephalitic alphaviruses, causing mortality in a majority of symptomatic cases and neurological sequelae in many survivors. Unlike many alphaviruses, NA-EEEV infection of mice yields limited signs of febrile illness typically associated with lymphoid tissue replication. Rather, signs of brain infection, including seizures, are prominent. Use of heparan sulfate (HS) as an attachment receptor increases the neurovirulence of cell culture-adapted strains of Sindbis virus, an arthritogenic alphavirus. However, this receptor is not known to be used by naturally circulating alphaviruses. We demonstrate that wild-type NA-EEEV strain FL91-4679 uses HS as an attachment receptor and that the amino acid sequence of its E2 attachment protein is identical to those of natural isolates sequenced by RT-PCR amplification of field samples. This finding unequivocally confirms the use of HS receptors by naturally circulating NA-EEEV strains. Inactivation of the major HS binding domain in NA-EEEV E2 demonstrated that the HS binding increased brain replication and neurologic disease but reduced lymphoid tissue replication, febrile illness signs, and cytokine/chemokine induction in mice. We propose that HS binding by natural NA-EEEV strains alters tropism in vivo to antagonize/evade immune responses, and the extreme neurovirulence of wild-type NA-EEEV may be a consequence. Therefore, reinvestigation of HS binding by this and other arboviruses is warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896745      PMCID: PMC3179095          DOI: 10.1073/pnas.1110617108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses.

Authors:  Eva Lee; Megan Pavy; Nicolie Young; Craig Freeman; Mario Lobigs
Journal:  Antiviral Res       Date:  2005-11-10       Impact factor: 5.970

2.  Binding of Sindbis virus to cell surface heparan sulfate.

Authors:  A P Byrnes; D E Griffin
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

3.  Clinical and neuroradiographic manifestations of eastern equine encephalitis.

Authors:  R L Deresiewicz; S J Thaler; L Hsu; A A Zamani
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

4.  Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses.

Authors:  Kate D Ryman; Christina L Gardner; Crystal W Burke; Kathryn C Meier; Joseph M Thompson; William B Klimstra
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

5.  Comparative sequence analysis of the eastern equine encephalitis virus pathogenic strains FL91-4679 and GA97 to other North American strains.

Authors:  Peter L Platteborze; John P Kondig; Randal J Schoepp; Leonar P Wasieloski
Journal:  DNA Seq       Date:  2005-08

6.  The furin protease cleavage recognition sequence of Sindbis virus PE2 can mediate virion attachment to cell surface heparan sulfate.

Authors:  W B Klimstra; H W Heidner; R E Johnston
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Early events in the pathogenesis of eastern equine encephalitis virus in mice.

Authors:  Peter Vogel; Wayne M Kell; David L Fritz; Michael D Parker; Randal J Schoepp
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

8.  Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor.

Authors:  W B Klimstra; K D Ryman; R E Johnston
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

9.  Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.

Authors:  F B Grieder; N L Davis; J F Aronson; P C Charles; D C Sellon; K Suzuki; R E Johnston
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

10.  Restricted and selective tropism of a Venezuelan equine encephalitis virus-derived replicon vector for human dendritic cells.

Authors:  Kevin P Nishimoto; Amanda K Laust; Kehui Wang; Kurt I Kamrud; Bolyn Hubby; Jonathan F Smith; Edward L Nelson
Journal:  Viral Immunol       Date:  2007       Impact factor: 2.257

View more
  57 in total

1.  Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.

Authors:  Christina L Gardner; Crystal W Burke; Stephen T Higgs; William B Klimstra; Kate D Ryman
Journal:  Virology       Date:  2012-02-01       Impact factor: 3.616

Review 2.  Role of heparan sulfate in sexually transmitted infections.

Authors:  Vaibhav Tiwari; Erika Maus; Ira M Sigar; Kyle H Ramsey; Deepak Shukla
Journal:  Glycobiology       Date:  2012-07-06       Impact factor: 4.313

3.  A Genome-Wide CRISPR-Cas9 Screen Reveals the Requirement of Host Cell Sulfation for Schmallenberg Virus Infection.

Authors:  Thiprampai Thamamongood; Andrea Aebischer; Valentina Wagner; Max W Chang; Roland Elling; Christopher Benner; Adolfo García-Sastre; Georg Kochs; Martin Beer; Martin Schwemmle
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

4.  Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection.

Authors:  Atsushi Tanaka; Uranan Tumkosit; Shota Nakamura; Daisuke Motooka; Natsuko Kishishita; Thongkoon Priengprom; Areerat Sa-Ngasang; Taroh Kinoshita; Naokazu Takeda; Yusuke Maeda
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

Review 5.  The sweet spot: defining virus-sialic acid interactions.

Authors:  Jennifer E Stencel-Baerenwald; Kerstin Reiss; Dirk M Reiter; Thilo Stehle; Terence S Dermody
Journal:  Nat Rev Microbiol       Date:  2014-09-29       Impact factor: 60.633

6.  An Evolutionary Insertion in the Mxra8 Receptor-Binding Site Confers Resistance to Alphavirus Infection and Pathogenesis.

Authors:  Arthur S Kim; Ofer Zimmerman; Julie M Fox; Christopher A Nelson; Katherine Basore; Rong Zhang; Lorellin Durnell; Chandni Desai; Christopher Bullock; Sharon L Deem; Jonas Oppenheimer; Beth Shapiro; Ting Wang; Sara Cherry; Carolyn B Coyne; Scott A Handley; Michael J Landis; Daved H Fremont; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2020-02-18       Impact factor: 21.023

7.  Rapid and Sparse Labeling of Neurons Based on the Mutant Virus-Like Particle of Semliki Forest Virus.

Authors:  Fan Jia; Xutao Zhu; Pei Lv; Liang Hu; Qing Liu; Sen Jin; Fuqiang Xu
Journal:  Neurosci Bull       Date:  2019-03-19       Impact factor: 5.203

8.  Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.

Authors:  Alison W Ashbrook; Kristina S Burrack; Laurie A Silva; Stephanie A Montgomery; Mark T Heise; Thomas E Morrison; Terence S Dermody
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

9.  Macromolecular Synthesis Shutoff Resistance by Myeloid Cells Is Critical to IRF7-Dependent Systemic Interferon Alpha/Beta Induction after Alphavirus Infection.

Authors:  Nishank Bhalla; Christina L Gardner; Sierra N Downs; Matthew Dunn; Chengqun Sun; William B Klimstra
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

10.  Cryo-EM structure of eastern equine encephalitis virus in complex with heparan sulfate analogues.

Authors:  Chun-Liang Chen; S Saif Hasan; Thomas Klose; Yingyuan Sun; Geeta Buda; Chengqun Sun; William B Klimstra; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.